Magnetic resonance (MR) imaging is potentially a well-suited modality
to guide clinical management of patients with myocardial ischemia and
infarction. Evaluation of regional perfusion and contractile function
distinguishes between normal and ischemic myocardium and identifies ar
eas of infarction, stunning, and hibernation. Recent technical improve
ments in MR perfusion imaging include the use of echoplanar and fast g
radient-echo sequences to capture the first pass of MR contrast agents
through the myocardium. Evaluation of regional function will likely b
enefit from motion-encoded MR imaging, which employs tissue tagging or
cine phase-contrast to track the myocardial motion throughout the car
diac cycle. Stress imaging with dobutamine and dipyridamole will furth
er enhance the accuracy of MR myocardial imaging. Advantages of MR ima
ging over other available noninvasive modalities include its good spat
ial resolution and the potential for three-dimensional imaging without
the need for geometric assumptions. Importantly, a single comprehensi
ve MR examination can assess not only regional myocardial perfusion an
d function, but in addition also global ventricular size and function
and (perhaps) coronary artery anatomy and flow. Such integrated cardia
c evaluation may turn out to be a cost-effective strategy. Large clini
cal trials incorporating outcome analysis are now needed to see whethe
r cardiac MR imaging can live up to the current high expectations.